The aims of our study were to first investigate the possible cardioprotective impact of tamsulosin against MI and to then explore the potential mechanisms by which tamsulosin mediates the attenuation of MI and determine whether this occurs via modulation of an ILK-related TGFβ/Smad signaling pathway. The gene discussed is TGFB1; the disease is myocardial infarction.